T he Third Report of the National Cholesterol Education ProgramAdult Treatment Panel (NCEPATP III) and the Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice recommended a low-density lipoprotein cholesterol (LDL-C) target of <100 mg/dl for patients with coronary heart disease (CHD). Indeed, the GREek Atorvastatin and Coronary heart ...

BACKGROUND This study estimated prevalence of unhealthy weight status and metabolic syndrome (MS) amongst Saudi survivors of standard risk ALL. PROCEDURE We recruited 56 survivors, mean age 13.4 years (SD 4.1), a mean of 9.1 years (SD 4.1) post-diagnosis. The BMI for age was used to define weight status relative to national (Saudi) and international (Cole et al., Cole-IOTF, WHO, and CDC) refe...

Background. Gallbladder polyps are usually benign lesions originating from the mucosa and detected incidentally during radiological examinations or after cholecystectomy. common may have malignant risk. In this study, it was investigated whether metabolic syndrome (MS) is a risk factor for gallbladder polyps. This study aimed to determine prevalence of MS its components in patients with Materia...

INTRODUCTION Hypertriglyceridemia is an independent risk factor for coronary heart disease (CHD), according to the guidelines from the Third Report of the National Cholesterol Education Program Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP ATP III). High triglyceride (TG) levels are frequently found in combination with insulin resistance, obe...

BACKGROUND/AIMS To compare the frequency of metabolic syndrome (MetS) and magnitude of insulin resistance, measured by the homeostatic model assessment of insulin resistance (HOMA-IR), between South Korean women with rheumatoid arthritis (RA) and healthy subjects, and to evaluate risk factors for MetS and increased HOMA-IR in patients with RA. METHODS In a cross-sectional setting, 84 female p...

The cooccurrence of diabetes mellitus and metabolic syndrome potentiates the cardiovascular risk associated with each of the conditions; therefore characterizing metabolic syndrome among people with type 2 diabetes is beneficial for the purpose of cardiovascular disease prevention. This study aims at evaluating the prevalence of metabolic syndrome and its components among 162 patients with type...

OBJECTIVE To characterize the body composition, to determine the prevalence of metabolic syndrome (MetS), and to examine the association between body composition and the components of MetS in Vietnamese patients with primary gout. METHODS A total of 107 males with gout and 107 age-matched healthy males underwent physical examination, body composition assessment by dual-energy X-ray absorptiom...

BACKGROUND Metabolic syndrome (MetS) is the major risk factor for development of type 2 diabetes and cardiovascular diseases in different populations. The aim of this study was to evaluate the prevalence of MetS among Iranian population. METHODS Thirty-four cross-sectional studies were analyzed with a sample of 83227 people. National and international English electronic databases (PubMed, Goo...

OBJECTIVE There is a need for a simple and accurate method for the assessment of cardiovascular risk in polycystic ovary syndrome (PCOS). Lipid accumulation product (LAP) is based on the assessment of waist circumference and serum triglycerides that yield an estimation of lipid overaccumulation. We aimed to determine whether LAP is associated with metabolic syndrome (MetS) in Caucasian women wi...